OMEROS CORP Adjustments to Additional Paid in Capital, Warrant Issued
OMEROS CORP (OMER) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.42 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2021-03-01
- OMEROS CORP adjustments to additional paid in capital, warrant issued for the quarter ending 2016-12-31 was $0.00.
- OMEROS CORP adjustments to additional paid in capital, warrant issued for the quarter ending 2016-09-30 was $0.00.
- OMEROS CORP adjustments to additional paid in capital, warrant issued for the quarter ending 2015-09-30 was $0.00.
- OMEROS CORP adjustments to additional paid in capital, warrant issued for fiscal 2018 was $1.42M.
- OMEROS CORP adjustments to additional paid in capital, warrant issued for fiscal 2016 was $758.00K.
- OMEROS CORP adjustments to additional paid in capital, warrant issued for fiscal 2014 was $863.00K, a 2004.88% increase from fiscal 2013.
- OMEROS CORP adjustments to additional paid in capital, warrant issued for fiscal 2013 was $41.00K, a 91.98% decline from fiscal 2012.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $1.42M 10-K · filed 2021-03-01 | $55.66M 10-K · filed 2019-03-01 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $758.00K 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $758.00K 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $758.00K 10-Q · filed 2016-08-09 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | ||||
| 2014-12-31 | $863.00K 10-K · filed 2017-03-16 | ||||
| 2013-12-31 | $41.00K 10-K · filed 2016-03-15 | ||||
| 2012-12-31 | $511.00K 10-K · filed 2015-03-16 | ||||
| 2010-12-31 | $994.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |